https://www.thebodypro.com/category/providing-quality-hiv-care/tag/news

The Latest

This Week in HIV Research: Maintenance Therapy Regimen Containing Lamivudine May Be Viable Option Img

This Week in HIV Research: Maintenance Therapy Regimen Containing Lamivudine May Be Viable Option

This week, a study finds that a treatment regimen containing lamivudine may work as maintenance therapy for those already virally suppressed.

Why Did the Opioid Epidemic Develop and How Do We Stop It? Img

Why Did the Opioid Epidemic Develop and How Do We Stop It?

During the last 18 years, both the amount of prescription opioids and the number of deaths attributed to these drugs has quadrupled in the U.S., Glenn J. Treisman, M.D., Ph.D., said in a recent webinar.

This Week in HIV Research: Stable Housing Improves Viral Suppression and CD4 Counts Img

This Week in HIV Research: Stable Housing Improves Viral Suppression and CD4 Counts

This week, a study finds that stable housing can improve CD4 counts and viral load suppression rates in people with HIV.

This Week in HIV Research: Continuous Treatment Adherence Increases; and Programs Needed for Quitting Smoking Img

This Week in HIV Research: Continuous Treatment Adherence Increases; and Programs Needed for Quitting Smoking

This week, a study finds that continuous HIV treatment adherence, without a 90-day gap, has increased between 2001 and 2010, and is now longer than adherence to medication for some other chronic diseases.

This Week in HIV Research: Spotlight on HIV Cure Research, and TAF vs. TDF in Triple-Drug Regimens Img

This Week in HIV Research: Spotlight on HIV Cure Research, and TAF vs. TDF in Triple-Drug Regimens

This week, a special issue of The Journal of Infectious Diseases highlights HIV cure research. And a study compares TAF and TDF in triple-drug regimens.

This Week in HIV Research: Multidrug-Resistant HIV Widespread in Kenya; and Bictegravir vs. Dolutegravir Img

This Week in HIV Research: Multidrug-Resistant HIV Widespread in Kenya; and Bictegravir vs. Dolutegravir

This week, a study finds that a quarter of Kenyans with HIV who have experienced second-line treatment failure have multidrug-resistant HIV.

This Week in HIV Research: Non-AIDS Cancers More Common as People With HIV Age Img

This Week in HIV Research: Non-AIDS Cancers More Common as People With HIV Age

This week, a study finds that as people living with HIV continue to age, the prevalence of non-AIDS-defining cancers will go up.

This Week in HIV Research: Earlier Diagnoses Needed to Reduce Mortality; and Challenges in Treating Adolescents With HIV Img

This Week in HIV Research: Earlier Diagnoses Needed to Reduce Mortality; and Challenges in Treating Adolescents With HIV

This week, a study finds that people living with HIV have a higher mortality rate than general population, often because of AIDS-defining illnesses, highlighting the importance of earlier HIV diagnoses.

This Week in HIV Research: Depression Does Not Increase Mortality Risk Among People With HIV Img

This Week in HIV Research: Depression Does Not Increase Mortality Risk Among People With HIV

This week, a study finds that for individuals living with HIV, experiencing symptoms of depression does not increase mortality risk. Another study finds that common sexual practices among pregnant women in Kenya may decrease the effectiveness of some...

This Week in HIV Research: Treatment at Diagnosis Prevents Bacterial Infections; and Expanding PrEP Capacity Img

This Week in HIV Research: Treatment at Diagnosis Prevents Bacterial Infections; and Expanding PrEP Capacity

This week, a study finds that starting antiretroviral therapy immediately after diagnosis lowered the risk of severe bacterial infections. Another study finds that providers in the San Francisco area are wiling to prescribe pre-exposure prophylaxis (...